These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15077480)

  • 21. Saphenoperitoneal shunts for patients with intractable ascites associated with chronic liver disease (Br J Surg 1999;86:882-5).
    Vercruysse GA; Reed DN
    Br J Surg; 2002 Feb; 89(2):245. PubMed ID: 11862952
    [No Abstract]   [Full Text] [Related]  

  • 22. Peritoneovenous shunting is an effective treatment for intractable ascites.
    Sooriakumaran P; McAndrew HF; Kiely EM; Spitz L; Pierro A
    Postgrad Med J; 2005 Apr; 81(954):259-61. PubMed ID: 15811892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of patients with portal hypertension complicated by resistant ascites].
    Ibadil'din AS; Andreev GN; Tripol'skaia GI; Akhmetova ZhD
    Vestn Khir Im I I Grek; 1985 Aug; 135(8):32-5. PubMed ID: 4060505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peritoneovenous shunting in intractable ascites.
    Deans GT; Spence RA; Johnston GW
    Ulster Med J; 1985 Oct; 54(2):155-9. PubMed ID: 4095803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Peritoneovenous Shunt for the Management of Refractory Ascites.
    Ayllón MD; Ciria R; Gómez-Luque I; Rodriguez-Perálvarez M; Padial A; Luque A; López-Cillero P; de la Mata M; Briceño J
    Transplant Proc; 2019; 51(1):41-43. PubMed ID: 30655143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Palliative treatment of malignant refractory ascites by positioning of Denver peritoneovenous shunt.
    Zanon C; Grosso M; Aprà F; Clara R; Bortolini M; Quaglino F; Cornaglia S; Simone P
    Tumori; 2002; 88(2):123-7. PubMed ID: 12088251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peritoneal venous shunting for ascites: a 15-year perspective.
    Hyde GL; Dillon M; Bivins BA
    Am Surg; 1982 Mar; 48(3):123-7. PubMed ID: 7073133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peritoneovenous shunting for intractable ascites.
    Tyden G; Samnegård H; Thulin L
    Acta Chir Scand; 1982; 148(7):597-600. PubMed ID: 7168289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous implant of Denver peritoneo-venous shunt for treatment of refractory ascites: a single center retrospective study.
    Piccirillo M; Rinaldi L; Leongito M; Amore A; Crispo A; Granata V; Aprea P; Izzo F
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3668-3673. PubMed ID: 28925475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peritoneovenous shunt in malignant ascites. The Bordet Institute experience from 1975-1998.
    Tueche SG; Pector JC
    Hepatogastroenterology; 2000; 47(35):1322-4. PubMed ID: 11100342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Successful treatment for intractable ascites with uterine cancer using double Denver peritoneovenous shunt system].
    Kawamoto J; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Nozawa S; Furukawa K; Mitsuhashi N; Takeuchi D; Suda K; Yoshioka I; Miyazaki M
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1919-23. PubMed ID: 17212147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peritoneovenous shunts for malignant ascites.
    Sonnenfeld T; Tydén G
    Acta Chir Scand; 1986 Feb; 152():117-21. PubMed ID: 3953206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early implantation of Denver shunt.
    Oida T; Mimatsu K; Kawasaki A; Kano H; Kuboi Y; Fukino N; Kida K; Matsuoka S; Amano S
    Hepatogastroenterology; 2011; 58(112):2026-8. PubMed ID: 22234072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of peritoneal venous shunting for intractable neonatal ascites: a short case series.
    Herman R; Kunisaki S; Molitor M; Gadepalli S; Hirschl R; Geiger J
    J Pediatr Surg; 2011 Aug; 46(8):1651-4. PubMed ID: 21843738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indigenous cost-effective peritoneo-venous shunt for refractory ascites.
    Marimuthu K; Kumar AS; Sabanathan S; Gowrishankar A; Kumar PS; Rajkumar JS
    Int Surg; 2004; 89(2):85-9. PubMed ID: 15285240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent ascites can be effectively treated by peritoneovenous shunts.
    Rahman N; De Coppi P; Curry J; Drake D; Spitz L; Pierro A; Kiely E
    J Pediatr Surg; 2011 Feb; 46(2):315-9. PubMed ID: 21292080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salvaging procedures for dysfunctional peritoneovenous shunt.
    Hu RH; Lee PH
    Hepatogastroenterology; 2001; 48(39):794-7. PubMed ID: 11462926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Palliation of malignant ascites by the Denver peritoneovenous shunt.
    Downing R; Black J; Windsor CW
    Ann R Coll Surg Engl; 1984 Sep; 66(5):340-3. PubMed ID: 6207757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peritoneovenous shunt insertion for intractable ascites: a district general hospital experience.
    Hussain FF; Meer ZF; Lopez AJ
    Cardiovasc Intervent Radiol; 2004; 27(4):325-8. PubMed ID: 15346206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Denver peritoneovenous shunts for the management of malignant ascites: a review of the literature in the post LeVeen Era.
    White MA; Agle SC; Padia RK; Zervos EE
    Am Surg; 2011 Aug; 77(8):1070-5. PubMed ID: 21944526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.